Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Salim Hayek, MD, a cardiovascular specialist in cardio-oncology from the UTMB Health is joined by Amelia Langston, MD, a hematology and medical oncology specialist from Emory University to discuss their new AHA scientific statement on the cardiovascular management of patients undergoing hematopoietic stem cell transplantation (HSCT). They review the phases of HCST, the incidence of cardiovascular complications, long-term management, and the significance of survivorship post-transplant.
Recommended Videos
Addressing Hypertension Care for Uninsured and Underinsured Patients in a...
Addressing Non-English Speaking Patients in Team-based Hypertension Care i...
Key Statement Takeaways on Real-Life Implementation
Trinity Free Health Clinic's Collaborative Approach to Free Team-based Hyp...
A Community Project Example of Real-Life Implementation
Loading...
Save Video
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.